Effects of commonly used anti-anxiety drugs on patients

Not Applicable

• Registration Number: CTRI/2023/01/048752
• Lead Sponsor: Dr Dnyaneshwar Kurle

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 9 January 2023

Recruitment & Eligibility

• Status: ot Yet Recruiting
• Sex: Not specified
• Target Recruitment: 0

Inclusion Criteria

1. Patient with the age from 18 to 65 years diagnosed with anxiety disorder according to DSM V criteria of either sex will be included.

2. Patients and legal authorized representative willing to give informed consent and participate in the study.

3. Patient who are able to understand and do the computerized psychometric test.

4. Patients who are able to read or understand the prescriptions and pronounce the names of the drugs correctly.

Exclusion Criteria

1. Patients unwilling to participate

2. Pregnant or lactating patients.

3. Patients already receiving treatment for anxiety disorder

4. Patients admitted in Psychiatry IPD or emergency department.

5. Patients receiving treatment for any psychotic disorder such as schizophrenia, Alzheimerâ??s Syndrome or dementia or for substance abuse disorder.

6. Patients unable to perform the computerized psychometric tests after training session

7. Patients who suffer excessive stress and test anxiety during computerized psychometric testing

8. Patients who are not able to read or understand the prescriptions and pronounce the names of the drugs correctly.

9. Patients with serious diseases such as heart failure, chronic kidney disease or with suicidal ideation

Study & Design

• Study Type: Observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Change in psychometric function test scores over a 6 week periodTimepoint: Immediately and at follow up after 6 weeks, 18 month duration

Secondary Outcome Measures

Name	Time	Method
Change in anxiety rating scores over a 6 week periodTimepoint: Immediately and at follow up after 6 weeks, 18 month duration;Cost of drugs for treatment of anxiety disorders in patientsTimepoint: Single point, 18 month duration;Drugs prescribed for treatment of anxiety disorders in patientsTimepoint: Single point, 18 month duration;Level of disease and drug treatment awareness amongst patients with anxiety disorderTimepoint: Single point, 18 month duration